Veracyte, Inc. (VCYT) Q3 2016 Earnings Results

Veracyte Inc Misses on Revenue, Stock Down 4.38%

This earnings report indicates that while Veracyte Inc. managed to beat EPS expectations, the lack of revenue data and guidance may have raised concerns among investors. The stock reacted negatively, dropping 4.38%, likely due to uncertainty about future performance and the absence of specific guidance from management.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.20	N/A	+33.33%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Management expressed a cautious optimism about future growth despite not providing specific guidance. They emphasized the importance of their product pipeline.

Management highlighted ongoing efforts to expand product offerings.

They noted the importance of upcoming product launches.

Focus remains on improving operational efficiency.

Veracyte Inc Misses on Revenue, Stock Down 4.38%

Key numbers

Management commentary

Veracyte, Inc.

More earnings this week

Veracyte Inc Misses on Revenue, Stock Down 4.38%

Key numbers

Management commentary